title: A proliferation-inducing ligand (APRIL): the development of antagonistic agents as potential therapeutics and deciphering the role of heparan sulphate proteoglycans (HSPGs) in APRIL Signalling.
authors.affiliation: LEXOR (Laboratory of Experimental Oncology and Radiobiology), Center for Experimental Molecular Medicine, Academic Medical Center (AMC), University of Amsterdam, Room G2-140, 1105 AZ, Amsterdam, The Netherlands.
authors.forename: Fiona
authors.initials: F
authors.lastname: Kimberley
authors.forename: Marco
authors.initials: M
authors.lastname: Guadagnoli
authors.forename: Hans
authors.initials: H
authors.lastname: van Eenennaam
authors.forename: Jan Paul
authors.initials: JP
authors.lastname: Medema
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology* / Q000627:therapeutic use*; D055808:Drug Discovery; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism*; D006801:Humans; D051379:Mice; D015398:Signal Transduction / Q000187:drug effects*; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000037:antagonists & inhibitors* / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D019812:Heparan Sulfate Proteoglycans; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13